Amy Griffin

Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY.

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC.

HistoSonics, Inc. develops medical devices. The company was founded by Christine Gibbons, Jim Bertolina, Zhen Xu, William Robert, Hall Timothy, J. Brian Fowlkes, Thomas W. Davison, and Charles Cain in November 2009 and is headquartered in Ann Arbor, MI.

Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC.

Fish & Neave operates as a law firm. It specializes in specializes in intellectual property issues involving patents, trademarks, and copyrights. The company is headquartered in New York, NY.

National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD.

Soft Gel Technologies, Inc. provides soft gelatin encapsulation capibilities to the nutrition industry. Its products include 3-TriLean, CoQsol, Posinol, Injuv, LyCoQ, PharmaFew, and WasabiSol. The company was founded in 1995 and is headquartered in Los Angeles, CA.

The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX.

US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD.

National Comprehensive Cancer Network, Inc. provides research and development services to fight against cancer. The organization develops resources that present information to the numerous stakeholders in the health care delivery system. The company was founded in 1995 and is headquartered in Fort Washington, PA.

Compagnie Mérieux Alliance SAS owns shares and interests in firms that manufactures, sells, and distributes medicines and other pharmaceutical products. The company is headquartered in Lyon, France.

Manhattan Institute For Policy Research, Inc. develops and disseminate new ideas for greater economic choice and individual responsibility. It focuses on economic growth, education, energy and environment, health care, legal reform, public sector, race and urban policy. The company was founded by Antony Fisher and William J. Casey in 1977 and is headquartered in New York, NY.

Focused Ultrasound Foundation is an early-sage company, which engages in the provision of non-invasive therapeutic technology. It focuses on cardiovascular, endocrine disorders, gastrointestinal, musculoskeletal, neurological, oncological, urological, and women''s health sectors. The company was founded by Neal F. Kassell and is headquartered in Charlottesville, VA.

Tornado Spectral Systems, Inc. develops real-time optical process analyzers and imaging solutions. Its optical solutions include HyperFlux PRO Plus, HyperFlux PRO and HyperFlux U1. The firm offers its services to pharmaceuticals, oil and gas, bio processing, specialty chemical, plastics and polymers industries. The company was founded by Jae Kim and Arsen R. Hajian in 2010 and is headquartered in Toronto, Canada.

Company Builders LLC provides business development consulting services. The private company is based in Albuquerque, NM. The CEO of the company is Paul Andrew Ruppanner.

Memed Diagnostics Ltd. engages in the development and commercialization of diagnostic solutions for inflammatory and infectious diseases. Its products include MeMed BV and MeMed Key, devices for blood test and quantitative diagnostic immunoassays. The company was founded by Eran Eden and Kfir Oved in 2009 and is headquartered in Tirat Carmel, Israel.

Qvella Corp provides molecular diagnostics. It develops a differentiated technology for pathogen detection by direct sampling of boldily fluids without the need for culturing or time consuming sample processing. The company was founded by Tino Alavie in 2009 and is headquartered in Richmond Hill, Canada.

Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada.

Calviri, Inc. operates as a biotech company. It focuses on diagnostics for the early detection of cancer and for vaccines to eliminate cancer. The company was founded by Stephen Albert Johnston and is headquartered in Tempe, AZ.

Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada.

Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom.

OMX Ventures LLC (OMX Ventures) is a venture capital firm founded in 2020. The firm is headquartered in Lincolnshire, Illinois.

Part of Bayer AG, BlueRock Therapeutics LP is a clinical stage cell therapy company focused on creating cellular medicines to reverse devastating diseases. The company is based in Cambridge, MA. In late 2019, BlueRock became a wholly owned, independently operated subsidiary of Bayer AG as a cornerstone of its newly formed cell & gene therapy platform. The company's culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that they are all part of something bigger than themselves. BlueRock Therapeutics' lead clinical program, Bemdaneprocel (BRT-DA01), is in phase I clinical trials for Parkinson's disease. BlueRock Therapeutics was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer, the impact investing arm of Bayer AG. Seth Ettenberg has been the CEO of the company since 2020.